Sensus Healthcare (NASDAQ:SRTS – Get Free Report) and Microbot Medical (NASDAQ:MBOT – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.
Get Sensus Healthcare alerts:
Analyst Ratings
This is a summary of recent ratings and recommmendations for Sensus Healthcare and Microbot Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sensus Healthcare | 0 | 0 | 2 | 1 | 3.33 |
| Microbot Medical | 0 | 0 | 1 | 0 | 3.00 |
Sensus Healthcare presently has a consensus price target of $10.00, indicating a potential upside of 55.52%. Microbot Medical has a consensus price target of $7.00, indicating a potential upside of 600.00%. Given Microbot Medical’s higher possible upside, analysts clearly believe Microbot Medical is more favorable than Sensus Healthcare.
Profitability
This table compares Sensus Healthcare and Microbot Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sensus Healthcare | 18.27% | 13.78% | 12.34% |
| Microbot Medical | N/A | -149.24% | -115.69% |
Valuation & Earnings
This table compares Sensus Healthcare and Microbot Medical’s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sensus Healthcare | $24.41 million | 4.32 | $490,000.00 | $0.29 | 22.17 |
| Microbot Medical | N/A | N/A | -$10.74 million | ($0.89) | -1.12 |
Sensus Healthcare has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 11.1% of Sensus Healthcare shares are owned by insiders. Comparatively, 10.6% of Microbot Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Risk & Volatility
Sensus Healthcare has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Microbot Medical has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500.
Summary
Sensus Healthcare beats Microbot Medical on 12 of the 14 factors compared between the two stocks.
About Sensus Healthcare
(Get Free Report)
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
About Microbot Medical
(Get Free Report)
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
